Orthocell receives regulatory approval for Striate+ in Singapore
PERTH: Orthocell Limited, a regenerative medicine company, announced on March 18, 2025, that it has received regulatory approval from Singapore’s Health Sciences Authority (HSA) for its dental membrane product, Striate+. This approval allows the company to begin sales in Singapore, a key…